Drug or treatment
Prasinezumab clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Prasinezumab that are recruiting, at sites in 19 countries (most in France (2), Germany (2), Italy (2)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 19Countries
All recruiting trials (2)
-
IV prasinezumab treatment for people with early-stage Parkinson's disease
This study will try IV prasinezumab versus placebo in people with early-stage Parkinson's disease who are on stable levodopa monotherapy.
-
Prevent cognitive decline in GBA-related Parkinson's with a monoclonal antibody
This trial tests whether prasinezumab can slow cognitive decline in people with Parkinson's who carry a severe GBA gene mutation.
Quick answers
How many clinical trials of Prasinezumab are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in France (2 trials), Germany (2 trials), Italy (2 trials), Spain (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.